Snoring kids may skip surgery: nasal spray trial shows promise

NCT ID NCT05382494

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a steroid nasal spray (mometasone furoate) in 130 children aged 3-12 who snore and have sleep-disordered breathing. The goal was to see if the spray could relieve symptoms enough to avoid surgery to remove tonsils or adenoids. Children used the spray daily for 6 weeks, and their symptoms were tracked using a parent questionnaire.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Mometasone Furoate nasal spray
What this could lead to
If it works, this nasal spray could offer a non-surgical option for children with snoring and sleep-disordered breathing, potentially reducing the need for tonsil or adenoid removal.
What could go wrong
This is a small, completed Phase 4 trial. The steroid spray may not work better than saline, and long-term effects in children are not fully known. Results may not apply to all kids.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADENOIDAL DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Monash Children's Hospital

    Clayton, Victoria, 3168, Australia

  • Royal Children's Hospital / Murdoch Children's Research Institute

    Parkville, Victoria, 3052, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.